PortfoliosLab logoPortfoliosLab logo
NMR vs. MS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NMR vs. MS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Nomura Holdings, Inc. (NMR) and Morgan Stanley (MS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NMR achieves a 17.69% return, which is significantly lower than MS's 20.48% return. Over the past 10 years, NMR has underperformed MS with an annualized return of 11.14%, while MS has yielded a comparatively higher 25.84% annualized return.


NMR

1D
1.26%
1M
6.84%
6M
11.32%
YTD
17.69%
1Y
51.35%
3Y*
42.24%
5Y*
18.24%
10Y*
11.14%
ALL TIME*
0.36%

MS

1D
0.72%
1M
-1.10%
6M
16.37%
YTD
20.48%
1Y
54.71%
3Y*
36.38%
5Y*
20.78%
10Y*
25.84%
ALL TIME*
13.01%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$1.18B$1.27B$1.26B
$9.47M$10.59M$11.46M

NMR vs. MS - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
NMR
Nomura Holdings, Inc.
17.69%54.10%34.05%21.84%-10.28%-18.76%4.39%38.71%-36.08%0.16%
MS
Morgan Stanley
20.48%45.16%39.73%13.93%-10.34%46.65%38.09%32.67%-22.76%26.61%

Correlation

The correlation between NMR and MS is 0.53, which is moderate. They have sometimes moved together and sometimes differently, sharing some price drivers without tracking each other closely.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.53

Correlation (3Y)
Balances recent behavior with more history.

0.43

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.46

Correlation (10Y)
Provides a long-term view across more market conditions.

0.44

Correlation (All Time)
Calculated using the full available price history since May 16, 1995

0.33

The correlation between NMR and MS shifts across timeframes, from 0.33 (all time) to 0.53 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

NMR:

$28.29B

MS:

$332.03B

EPS

NMR:

¥133.09

MS:

$11.41

PE Ratio

NMR:

11.45

MS:

18.43

PEG Ratio

NMR:

0.29

MS:

1.73

PS Ratio

NMR:

0.93

MS:

2.79

PB Ratio

NMR:

1.20

MS:

3.21

Total Revenue (TTM)

NMR:

¥4.94T

MS:

$120.22B

Gross Profit (TTM)

NMR:

¥2.30T

MS:

$69.72B

EBITDA (TTM)

NMR:

¥684.13B

MS:

$27.21B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NMR vs. MS — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

NMR
NMR Risk / Return Rank: 8585
Overall Rank
NMR Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
NMR Sortino Ratio Rank: 8484
Sortino Ratio Rank
NMR Omega Ratio Rank: 8585
Omega Ratio Rank
NMR Calmar Ratio Rank: 8282
Calmar Ratio Rank
NMR Martin Ratio Rank: 8383
Martin Ratio Rank

MS
MS Risk / Return Rank: 8787
Overall Rank
MS Sharpe Ratio Rank: 9090
Sharpe Ratio Rank
MS Sortino Ratio Rank: 8686
Sortino Ratio Rank
MS Omega Ratio Rank: 8686
Omega Ratio Rank
MS Calmar Ratio Rank: 8585
Calmar Ratio Rank
MS Martin Ratio Rank: 8888
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

NMR vs. MS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Nomura Holdings, Inc. (NMR) and Morgan Stanley (MS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


NMRMSDifference
Sharpe ratioReturn per unit of total volatility

-0.07

Sortino ratioReturn per unit of downside risk

-0.11

Omega ratioGain probability vs. loss probability

1.30

1.31

-0.01

Calmar ratioReturn relative to maximum drawdown

2.33

2.72

-0.39

Martin ratioReturn relative to average drawdown

6.23

8.59

-2.36

NMR vs. MS - Sharpe Ratio Comparison

The current NMR Sharpe Ratio is 1.78, which is comparable to the MS Sharpe Ratio of 1.84. The chart below compares the historical Sharpe Ratios of NMR and MS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

NMR vs. MS - Drawdown Comparison

The maximum NMR drawdown since its inception was -89.27%, roughly equal to the maximum MS drawdown of -88.12%. Use the drawdown chart below to compare losses from any high point for NMR and MS.


Loading charts...

Drawdown Indicators


NMRMSDifference

Max Drawdown

Largest peak-to-trough decline

-89.27%

-88.12%

-1.15%

Max Drawdown (1Y)

Largest decline over 1 year

-22.43%

-18.83%

-3.60%

Max Drawdown (3Y)

Largest decline over 3 years

-26.34%

-29.24%

+2.90%

Max Drawdown (5Y)

Largest decline over 5 years

-40.69%

-32.38%

-8.31%

Max Drawdown (10Y)

Largest decline over 10 years

-55.34%

-51.33%

-4.01%

Current Drawdown

Current decline from peak

-51.49%

-7.43%

-44.06%

Average Drawdown

Average peak-to-trough decline

-61.46%

-33.57%

-27.89%

Ulcer Index

Depth and duration of drawdowns from previous peaks

8.37%

5.96%

+2.41%

Volatility

NMR vs. MS - Volatility Comparison

The current volatility for Nomura Holdings, Inc. (NMR) is 8.53%, while Morgan Stanley (MS) has a volatility of 10.15%. This indicates that NMR experiences smaller price fluctuations and is considered to be less risky than MS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NMRMSDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.53%

10.15%

-1.62%

Volatility (6M)

Calculated over the trailing 6-month period

23.88%

22.56%

+1.32%

Volatility (1Y)

Calculated over the trailing 1-year period

29.42%

27.83%

+1.59%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

29.93%

28.82%

+1.11%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

30.26%

31.37%

-1.11%

Dividends

NMR vs. MS - Dividend Comparison

NMR's dividend yield for the trailing twelve months is around 3.35%, more than MS's 1.97% yield.


PositionTTM20252024202320222021202020192018201720162015
MS
Morgan Stanley
1.97%2.17%2.82%3.49%3.47%2.14%2.04%2.54%2.77%1.72%1.66%1.73%
NMR
Nomura Holdings, Inc.
3.35%4.91%4.29%1.20%3.86%0.00%0.86%0.00%0.00%1.70%1.79%3.34%

Financials

NMR vs. MS - Financials Comparison

This section allows you to compare key financial metrics between Nomura Holdings, Inc. and Morgan Stanley. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

NMR vs. MS - Profitability Comparison

The chart below illustrates the profitability comparison between Nomura Holdings, Inc. and Morgan Stanley over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

NMR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Nomura Holdings, Inc. reported a gross profit of 612.38B and revenue of 1.30T. Therefore, the gross margin over that period was 47.2%.

MS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Morgan Stanley reported a gross profit of 20.48B and revenue of 33.15B. Therefore, the gross margin over that period was 61.8%.

NMR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Nomura Holdings, Inc. reported an operating income of 211.54B and revenue of 1.30T, resulting in an operating margin of 16.3%.

MS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Morgan Stanley reported an operating income of 7.01B and revenue of 33.15B, resulting in an operating margin of 21.2%.

NMR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Nomura Holdings, Inc. reported a net income of 145.56B and revenue of 1.30T, resulting in a net margin of 11.2%.

MS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Morgan Stanley reported a net income of 5.64B and revenue of 33.15B, resulting in a net margin of 17.0%.


Frequently Asked Questions


NMR and MS have a correlation of 0.53, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MS has higher volatility (10.15%) compared to NMR (8.53%). In terms of maximum drawdown, NMR dropped -89.27% vs MS's -88.12%.

MS currently has the higher Sharpe Ratio (1.84 vs 1.78), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NMR and MS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer